Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Happy Passover
Big offering coming in June
About $25m
This will push the stinker down in the low $1s
Cheers
New sec filing.
Options converted
April Fools
Stinker headed to $1
Nugget Time
I have seen the light! I have closed out my short position. I couldn't fool you guys.
I have now gone Long.
I bought 45K shares the last few days. I wanted them cheapies, real bad.
Geert, I believe! Will you forgive me?
In addition, a little birdie told me that things are moving very, very quickly in Canada. Like real quick
Go CVM
Baha.
Lock him up
Go pray on that book of fiction for your demigod.
Cheers
Poor Gavin
A little birdie told me Gavin has received "numerous" calls today about Geert's clandestine Secondary Endpoint changes
He is "very annoyed" is the exact wording
Nuggets matter.
Cheers!
Chirp Chirp
Its Nugget Time
When CVM initiated its Phase III trial, it had 3 Secondary Endpoints. Just 3. This was the plan approved by the FDA
In June of 2021, CVM announced that the Trial Failed its Primary Endpoint. Failed
What CVM didn’t share and has yet to share, the Trial also Failed its 3 Secondary Endpoints. Not 1 PR not 1 Slide shows a successful Secondary Endpoint. Woof!
So what did Geert secretly do in August of 2022? He changed the 3 Secondary Endpoints and added 6 NEW ones. This is data Mining 101.
Go check out the Clinical Registry. See what he did. He secretly added 6 NEW post ad hoc Secondary Endpoints. No PR. No Tweet. He thought no one would notice.
The FDA has already stated it considers subgroup analyses exploratory and not enough on their own to justify approval on their own.
Geert needed a win. He is making up new post data Secondary Endpoints. A big no no
When presented with this information to “The Q” on iHub yesterday, his response was “It doesn’t look good”
22 Months and No BLA filing.
Shameful.
Go find 1 approved drug that Failed its primary and then had Secondary Endpoints added AFTER data analysis.
Ill be here all day
Chirp Chirp
All great questions
But the FDA hates data mining
This is post ad hoc data analysis
Boom!
Q
Ready for some real knowledge. Some real DD?
You’re not going to like this
When the trial started, there were 3 I repeat 3 secondary endpoints. The ones I posted.
However, geert secretly added a handful more in august 2022
It’s all verifiable on the clinical registry
All time stamped
Why did geert secretly add new secondary end points?
Where did they come from?
Data mining 101
Call Gavin
Ask him why no pr was done when they did that. ?
Scam 101
There were 3 secondary endpoints for the phase 3 trial
All failed per the Clinical Trial website
A subgroup or an Arm is not a secondary endpoint. FACT. But its fun to imagine!
Please show me any PR or slide from CVM detailing their secondary endpoint success.
You can’t cause it didn’t happen.
1 primary endpoint and 3 secondary endpoints. All failed.
Here are the 3 ORIGNAL Secondary Endpoints per the Clinical Trials site
Progression Free Survival (PFS) in LI + CIZ + SOC vs.SOC [ Time Frame: 3 year. ]
PFS will be assessed using Kaplan-Meier life-table and compared using a logrank test and confirmed further with stage location and geographic stratified log rank tests. The unstratified logrank test constitutes the primary analysis.A two sided p-value of 0.05 or less will be considered statistically significant in comparing the groups. The Holm closed-sequential procedure will be used to control type 1 error probability to at most 0.05
Local regional control (LRC) in LI + CIZ + SOC vs. SOC [ Time Frame: 2 years ]
LRC is assessed by classifying the first evidence of progression in local and distal sites for the control group and for the LI treated group. LRC failure includes progression of tumor(s) and nodes or appearance of new disease above the clavicle (but not distant metastases) the reappearance of tumor in the original tumor bed, development of cervical node metastases and new disease above the clavicle other than distant metastases not present at baseline. The number and percent of subjects in the treated and untreated groups and the timing of LRC will be displayed for each group.
Quality of Life (QOL) in LI + CIZ + SOC vs. SOC [ Time Frame: 3 yr. ]
QOL will be based on the EORTC QLOQ-C30 and EORTC QLQ-H&N35. QOL data will be assessed for change in QOL from baseline within and between treatment groups.Between group comparisons will be performed using ANOVA or Wilcoxon rank sum test. Within treatment group change from baseline will be performed using a paired t-test or a signed rank test. Two-sided t-test will be used with no adjustment for type I error. An exact binomial test of each treatment group will be used to assess a 10 point improvement between treatments. A Fisher Exact Test will be used for between group comparisons.
ALL THESE FAILED!
Wow!
Breaking news!
Tedt just spoke to Gavin
Geert is not interested in a Buyout. Details on YMB.
Poor Q. And by poor, I mean no money
Woof.
So many morons in this stock
It’s just comedic
I love watching this train wreck.
Shabbat shalom
Cheers
Why didn’t you sell when the stock hit $41
Cheers
Silicon Valley Bank?
I wonder how much of $CVM 's $12M cash (as of today) was tied up at Silicon Valley bank?
CVM will need an offering by June, but if they are exposed to SVB, perhaps much sooner!
Burning thru cash & had to give their Landlord another $2M last month for facility issues!
Woof!
Cheers
Where are all the loud mouth longs
Roll Call!
You had such high hopes and were played again
U never learn
Cheers
Y'all should of listened to me in Fall of 2021
Thats when I sold the last of my remaining shares at a gain. Remember, I loaded up Sub $1
This is on all of you!
You ignored the red flags. You deemed my comments as manipulation
This is on you!
You are NOT a victim
This is on you
This stinker is headed to $1, Chuckster
And for The Q "Thoughts and prayers" LOL
Cheers!
"Soon"
That is Geert's FAVORITE word..."soon"
22 Months and still NO prebla, but its "soon"
22 Months and still no BLA filing, but its "soon"
22 Months and still NO article in a journal, but its "soon"
30 Months and still NO verified facility, but its "soon"
"Soon"
Meanwhile, he continues to collect $1M in Compensation. He has slowed walked this for his personal gain!
Cheers
Good riddance. Unstable. False prophet. Failed expectations. This is all his doing
CASH RAISE NEEDED AROUND JUNE
Cash Balance at 12/31/22 was $18M (confirm with the 10-Q filed)
They have a $2M per month burn rate. (confirm with the 10-Q filed)
Thus at the end of March they will have about $12M.
But wait. Per the "subsequent events" note in the 10-Q, they had to give the landlord $2M extra. So now they will have only $10M at end of March.
At end of June $4M
Facts are tough
Geert will raise around June
Remember, per EF Hutton they dont expect to file the BLA until end of the year.
This stinker is headed to $1
The Lord wont save you Q
Cheers!
It’s called a cabin.
I can’t go up there this weekend as I’m having new floors put in
Cheers
There is no boogey man in the sky!
Bible is fiction
Cheers
The Q is on st complaining he has no money because of the recession
Poor Poor The Q
He was so so excited that I said I would leave the YMB if we closed over $3.25 today.
In fact, he made "3 thousand screenshots" of my post and he said today " I can almost say that I want this to close above $3.25 today more than I’ve wanted it to return to the $20s"
He is more concerned with me than Geerts lack of execution. How sad
Wash Rinse Repeat
Your failure to see what Geert is doing to you will be your downfall. Not a poster on a message board, Not Biden, but this will be all on you, Q
Lost opportunities galore since 2021. You should of been selling covered calls!
Any who. This stock is in the $2s. According to Q, thats just fine.
Cheers!
Why is this red? I thought this was a monster news
The Q on Yahoo Wrote this today
PRCruiseJunky
I can almost say that I want this to close above $3.25 today more than I’ve wanted it to return to the $20s.
I love it. I effing love this
I win again and again
Narrator: "It will never go above $10 ever again"
Cheers!
Primary Endpoint failed
This is data mining
Cheers
Woof
More data mining
I’m laughing at the q
PR out.
ONLY way to make money with CVM is swing trading
Congrats!
WOOF! CLOSED AT $2.89
Poor The Q
He is heartbroken again...
Odds of CVM closing above $3.25 tomorrow....
Sushi wins again
LOL
Cheers!
Woof!
Why is a Company's stock that is supposed to cure cancer back in the $2s.
I thought this NEW data tomorrow would send this stock to the MOON
Right The Q?
I have popped some popcorn and I will watch tomorrows Data Release with Glee!
Ta Ta for now
Cheers!
Pump it
Go higher
I want this to hit $4 tomorrow
(i cant wait until Wed)
Cheers!
Arent you a sweetie
Cheers!
Hey Dud!!!
Hows your CVM investment holding up?
Cheers!
Read this guys posts. He has reviewed the Poster presentation for next week.
https://stocktwits.com/Ollivanders
"Same as ASCO" but with a few different numbers. Nothing materially different
He goes on to say
"we have press releases and poster presentations. Neither of these are formal publications. Phase 3 data from a clinical trial is considered published when the results of the trial have been peer-reviewed and accepted for publication in a reputable scientific journal. Poster presentations provide valuable insights into ongoing research. Do not consider poster data as definitive or final until it has been fully analyzed and published in a peer-reviewed scientific journal. Of course figures of analyses can change. Reviewers do not check for spelling errors. "
Told ya
I cant wait to see this plummet on Wed.
Cheers!
This is so exciting I’m happy for all you
EF Hutton's Report was clear
NO BLA FILING UNTIL 2024
Cheers!
CVM's Phase III trial failed its Primary Endpoint
Now, after nearly 2 years, they are data mining
They found a subset of a subset....
Wont fly with the FDA
No pre bla meeting after 21 months
No certified facility after 21 months
BLA filing in 2024. Nearly 3 years later
But. But….3 posters to put on a wall.
Woof!
All the while, GK receives $1M in compensation a year
I wonder if the Offering will be in June or July!
cheers!
Shabbat Shalom!
How my Uber Longs feeling today!?
I guess that EF Hutton Report WAS correct
Cheers!